登入 加入會員 求助
 
Changchun Changsheng Life Sciences Ltd.
 
 
Recommended Results 
 
Varicella Vaccine,Live (gelatin free) 

  產品分類 : 化學->化學用品->aspalthic products

     
Varicella Vaccine,Live (gelatin free)
       

  產品規格
 
Model No:    0.5 ml/vial
  Country  CN
  Brand  WANXIN
  Minimum Order  5000
  Payment Term  L/C,T/T

 

  產品描述
   
  <p class="MsoNormal" style="margin-left:0.0000pt;text-align:justify;" align="justify">
<span> </span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal">
<span style="color:#333333;font-family:Roboto, Helvetica, Tahoma, Arial, Microsoft YaHei;background-color:#FFFFFF;">1. lyophilized&nbsp;</span><br />
<span style="color:#333333;font-family:Roboto, Helvetica, Tahoma, Arial, Microsoft YaHei;background-color:#FFFFFF;">2. gelatin-free ,</span>
</p>
<p class="MsoNormal">
3. Free of human serum albumin
</p>
4<span style="color:#333333;font-family:Roboto, Helvetica, Tahoma, Arial, Microsoft YaHei;background-color:#FFFFFF;">. live</span>
<p>
<br />
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
<span>[</span>Eligibles<span>]</span>
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
Varicella susceptible individuals at the age between 1 year old to 12 years old.
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
Varicella virus vaccine, live attenuated (oka strain) is indicated for:
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
&nbsp;- The active immunization against varicella of healthy subjects from 12 months to 12 years of age
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
&nbsp;- The active immunization against varicella of susceptible high-risk patients and their susceptible healthy close contacts in the age group of 12 months to 12 years .
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
<br />
</p>
<p class="MsoNormal" style="text-indent:24pt;">
[Specifications]
</p>
<p class="MsoNormal" style="text-indent:24pt;">
0.5ml of reconstituted vaccine per container. 0.5ml per single human dose containing not less than 3.4Lg PFU Oka virus.<span></span>
</p>
<p>
<br />
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
<span>[</span>Function and use<span>]</span>
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
The product can induce immunity against varicella-zoster virus in recipients following immunization. It is used to prevent varicella.
</p>
<p class="MsoNormal" style="text-indent:24.0000pt;">
<span>[</span>Advantages<span>]</span><b></b>
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(1)&nbsp;Have&nbsp;patent for invention of lyophilized protective agent, vaccine and its preparation method;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(2)&nbsp;Free of human serum albumin and gelatin with better security;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(3)&nbsp;Export to several countries for successive years and&nbsp;top the bestseller list in India;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(4)&nbsp;Obtained National Ten Famous-brand Products Honor Certificate in pharmaceutical industry;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(5)&nbsp;Gain exclusive approval document: one dose for one to twelve-year-old children as basic immunization, two doses for people no younger than 13 years old and if necessary, people below 12 years old could take one more dose (0.5ml) as booster immunization;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(6)&nbsp;Apply two dosage forms of pre-filled syringe from American BD Company and vial pack for security and convenience;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(7)&nbsp;Export to dozens of countries for successive years and top the bestseller list in India;
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
(8)&nbsp;With less clinical reaction, high-level immunogenicity, high conversion rate of serum antibody, high titer of antibody GMT, the Vaccine provides ideal protection after injection.
</p>
<p class="MsoNormal" style="margin-left:21.2500pt;text-indent:-21.2500pt;">
<br />
</p>
<p class="MsoNormal">
<b>Adverse reactions:</b><b></b>
</p>
<p class="MsoNormal">
<b>Common adverse reactions </b><b>(</b><b>≥10%):</b><b></b>
</p>
<p class="MsoNormal">
1) Redness, swelling, pain, itching etc.&nbsp;at the site of injection within 24 hours following the injection may be found, which could generally be relieved spontaneously within 2 or 3 days.
</p>
<p class="MsoNormal">
2) Temporal fever reaction may be found within 1 to 3 weeks after inoculation. It is mostly slight (ranging between 37.1~37.5<span>℃</span><span>) and can be relieved </span>spontaneously after one or two days. No specific treatment is necessary. If necessary, rest and increase in fluid intake may prevent secondary infection. For moderate fever (ranging between 37.6~39.0<span>℃</span><span>) or fever lasting for more than 48 hours, physical treatment or medication can be taken when necessary.</span>
</p>
<p class="MsoNormal">
3)&nbsp;interspersed rash or blebs may appear to few recipients probably within two weeks after injection.No special treatment is necessary. Symtomatic treatment could be helpful in case of need.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</p>
<p class="MsoNormal">
<b>&nbsp;</b>
</p>
<p class="MsoNormal">
<b>Rare adverse rea</b><b>c</b><b>tions (≥1% and ≤</b><b>10</b><b>%):</b><b></b>
</p>
<p class="MsoNormal">
Serious fever (body temperature above 39℃): Physical treatment or medication is needed to avoid febrile seizures.
</p>
<p class="MsoNormal">
<b>&nbsp;</b>
</p>
<p class="MsoNormal">
<b>Very rare adverse reactions</b><b>(<span><</span></b><b>1%):</b><b></b>
</p>
<p class="MsoNormal" align="justify" style="text-align:justify;">
1)&nbsp;Allergic skin rash: Urticaria allergic reaction may appear to several individuals within 72 hours after inoculation, and at this time immediate anti-allergic &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;therapy should be given.&nbsp;
</p>
<p class="MsoNormal" align="justify" style="text-align:justify;">
2)&nbsp;Allergic purpura: It may appear to very rare individuals.Timely therapy should be&nbsp;given properly with Cortico-5teroids drug. &nbsp;Improper therapy may induce&nbsp;purpura nephritis.
</p>
<p class="MsoNormal">
3) Occasional thrombocytopenic purpura may appear to several recipients.
</p>
<p>
<br />
</p>
<p>
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<img src="http://i.bosscdn.com/product/bb/af/cc/a05912d040ea3f3e6ed0fae4dc.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=5&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="Varicella vaccine" alt="Varicella vaccine" />
</p>ccls-vaccine.com

  其他類似產品
 
Group A and C Meningococcal Polysaccharide Vaccine

Group A and C Meningococcal Polysaccharide Vaccine
Bulk Rabies Vaccine For Human Use

Bulk Rabies Vaccine For Human Use
Preventing Chickenpox Immunization Vaccine

Preventing Chickenpox Immunization Vaccine
Lyophilized varicella vaccine, live

Lyophilized varicella vaccine, live
 
   


[ Back Products Catalog ]

Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
 
帳號:
密碼:
記住我的帳號
 
 
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容 ﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
   

 


公司簡介:

*公司名稱
*E-mail
*國家
*聯絡人
網址
*電話
- -
傳真
- -
*郵遞區號
*城市
*街道地址
*企業形態
批發商   出口商 進口商 製造商
大盤商 零售商  代理商 Retrofitter 使用者
其他, 請詳細說明:
*安全密碼
請輸入所顯示的安全密碼


網站導覽 l 隱私權政策 l 服務團隊 l 合作提案 l 聯絡我們 l 幫幫我 l 廣告刊登 l  B2B商業夥伴
    .